Cannabis Stocks Rise Ahead of Potential U.S. Federal Legalization Vote

Cannabis stocks rose higher on Thursday and into Friday, as the MORE Act could pass through the U.S. House next week.

edit Jars of marijuana

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Cannabis stocks rose on Thursday and into Friday, as the potential for a vote on cannabis legalization could be brought to the United States House of Representatives.

What happened?

Shares of cannabis stocks were up around 10%, with Tilray leading the charge at 22%. This came after news the U.S. House of Representatives officially have an act on their list of bills to cover on the floor in the coming week. It’s called the Marijuana Opportunity Reinvestment and Expungement Act, dubbed the MORE Act, and it’s not the first time we’ve seen it.

The Act originally came on the floor in December 2020, passing at that time but not making it through the Republican-controlled Senate. The bill would decriminalize marijuana, leading to the jump in prices that we saw today. Canopy Growth is up 10% on Friday, and Aurora Cannabis is up 13%.

So what?

The gains extended into Friday, as more information came out about the Act. The MORE Act would officially remove marijuana from the list of scheduled substances. Furthermore, a process would be established to remove previous cannabis convictions.

The Act will come back to the House on Monday, with a vote later that week. Unfortunately, even should it pass again, analysts don’t believe it will make it through the Senate this time. However, it’s a strong message to lawmakers that could create some stepping stones towards legalization.

Now what?

While the MORE Act may not pass the second round, there is a backup plan as well. This is called the Secure and Faire Enforcement Banking or SAFE Act. This Act is currently going through congress, and prohibits federal banking regulators from punishing banks that decide to work with cannabis companies in States that legalized its use.

Therefore, SAFE is a solid backup plan and could pass during the second half of this year. While legalization isn’t part of that, research on cannabis might be. And it all helps move the country forward towards decriminalization and legalization in the perhaps nearer future.

Shares of Tilray stock were up 7.5% on Friday, with Canopy Growth and Aurora Cannabis both up 2%.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe owns Canopy Growth Corp. The Motley Fool has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »